Developer of immunotherapy drugs for treatment of cancer. ITabMed is based in Shanghai, China and was founded in 2021. It has raised $20 million.
Team — not yet on record
No current team members for ITabMed are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ITabMed with a free account
- ·Watch ITabMed: the Monday email on marks, rounds and moves
